This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scatena, C. D. Articles by Adler, S. Search for Related Content PubMed PubMed Citation Articles by Scatena, C. D. Articles by Adler, S. Pubmed/NCBI databases OMIM Compound via MeSH Substance via MeSH

Characterization of a Human-Specific Regulator of Placental Corticotropin-Releasing Hormone

Departments of Obstetrics and Gynecology and Cell Biology and Physiology (S.A.) Washington University School of Medicine and the Division of Biology and Biomedical Sciences Program in Molecular and Cellular Biology (C.D.S., S.A.) Washington University St. Louis, Missouri 63110

The hypothalamic hormone CRH is also expressed in the placentas of humans and higher primates and may play an important role in the regulation of labor. In choriocarcinoma cell lines, activation of cAMP-dependent pathways increases human (h)CRH reporter gene expression. A cAMP-responsive region distinct from the cAMP response element at -220 bp, has been identified between -200 and -99 bp, and a candidate transcription factor was identified in nuclear extracts of human, but not rodent, choriocarcinoma cell lines.

This region, which does not contain a canonical cAMP response element (CRE), transfers protein kinase A responsiveness to a heterologous promoter. Electromobility shift assays and methylation and uracil interference studies localized factor binding to a 20-bp region from -128 to -109 bp of the hCRH promoter. This 20-bp fragment exhibited a similar shift in nuclear extracts from both human term placenta and from human JEG-3 cells. Base contacts, identified in interference studies, were confirmed as critical for binding, as a mutation of these bases abolished factor binding. Furthermore, a CRH promoter containing this mutation exhibited a diminished response to forskolin. UV cross-linking demonstrated the protein in nuclear extracts from human, but not rodent, choriocarcinoma cell lines and estimated its size as 58 kDa. Although this factor participates in cAMP-regulated gene expression, competition electrophoretic mobility assays demonstrated that the factor does not bind to a CRE. Furthermore, neither anti-CREB nor anti-ATF2 antibodies alter factor binding. These data identify this 58-kDa protein as the human-specific CRH activator previously identified as a candidate factor contributing to the species-specific expression of CRH in human placenta.

This article has been cited by other articles:

				E Yamamori, M Asai, M Yoshida, K Takano, K Itoi, Y Oiso, and Y Iwasaki Calcium/calmodulin kinase IV pathway is involved in the transcriptional regulation of the corticotropin-releasing hormone gene promoter in neuronal cells J. Mol. Endocrinol., December 1, 2004; 33(3): 639 - 649. [Abstract] [Full Text] [PDF]

				K. W. Cheng and P. C. K. Leung Human Chorionic Gonadotropin-Activated cAMP Pathway Regulates Human Placental GnRH Receptor Gene Transcription in Choriocarcinoma JEG-3 Cells J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3291 - 3299. [Abstract] [Full Text] [PDF]

				K. W. Cheng, B. K. C. Chow, and P. C. K. Leung Functional Mapping of a Placenta-Specific Upstream Promoter for Human Gonadotropin-Releasing Hormone Receptor Gene Endocrinology, April 1, 2001; 142(4): 1506 - 1516. [Abstract] [Full Text]

				A. Slominski, J. Wortsman, T. Luger, R. Paus, and S. Solomon Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress Physiol Rev, July 1, 2000; 80(3): 979 - 1020. [Abstract] [Full Text] [PDF]

				Y.-H. Cheng, R. C. Nicholson, B. King, E.-C. Chan, J. T. Fitter, and R. Smith Corticotropin-Releasing Hormone Gene Expression in Primary Placental Cells Is Modulated by Cyclic Adenosine 3',5'-Monophosphate J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1239 - 1244. [Abstract] [Full Text]

				T. Ramkumar and S. Adler A Requirement for the POU Transcription Factor, Brn-2, in Corticotropin-Releasing Hormone Expression in a Neuronal Cell Line Mol. Endocrinol., August 1, 1999; 13(8): 1237 - 1248. [Abstract] [Full Text]

				S. Wölfl, C. Martinez, and J. A. Majzoub Inducible Binding of Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Responsive Element Binding Protein (CREB) to a cAMP-Responsive Promoter in Vivo Mol. Endocrinol., May 1, 1999; 13(5): 659 - 669. [Abstract] [Full Text]

				K. A. Seth and J. A. Majzoub Repressor Element Silencing Transcription Factor/Neuron-restrictive Silencing Factor (REST/NRSF) Can Act as an Enhancer as Well as a Repressor of Corticotropin-releasing Hormone Gene Transcription J. Biol. Chem., April 20, 2001; 276(17): 13917 - 13923. [Abstract] [Full Text] [PDF]